⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL239548 | 0.97 | — | — | |
| SCHEMBL8056091 | 0.97 | — | — | |
| SCHEMBL8060438 | 0.97 | — | — | |
| SCHEMBL623962 | 0.93 | — | — | |
| SCHEMBL238200 | 0.85 | — | — | |
| SCHEMBL352864 | 0.80 | — | — | |
| SCHEMBL8055973 | 0.80 | ALDH1A1 (0.35) | — | |
| SCHEMBL8057798 | 0.80 | ALDH1A1 (0.33) | — | |
| SCHEMBL8044913 | 0.78 | — | — | |
| SCHEMBL352171 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199609-A1 | COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 | NOVARTIS AG (CH) | 2024-06-20 | — | — | US | claimed |
| EP-3921319-B1 | IMIDAZO [2, 1-F] [1, 2, 4] TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST | BEIGENE LTD (KY) | 2024-03-06 | — | — | EP | claimed |
| US-11905283-B2 | Compounds and compositions for inhibiting the activity of SHP2 | NOVARTIS AG (CH) | 2024-02-20 | — | — | US | claimed |
| WO-2023247590-A1 | TRIAZOLOPYRIDINE AND BENZOISOXAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS | ACTELION PHARMACEUTICALS LTD (CH) | 2023-12-28 | — | — | WO | claimed |
| US-20230167117-A1 | IMIDAZO[2,1-F][1,2,4]TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST | BEONE MEDICINES I GMBH (CH) | 2023-06-01 | — | — | US | claimed |
| US-20210300919-A1 | COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. | 2021-09-30 | — | — | US | claimed |
| US-10934285-B2 | Compounds and compositions for inhibiting the activity of SHP2 | NOVARTIS AG (CH) | 2021-03-02 | — | — | US | claimed |
| US-10723705-B2 | Heterocyclic compounds and uses thereof | INCYTE CORPORATION (US) | 2020-07-28 | — | — | US | claimed |
| EP-3468972-B1 | COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 | NOVARTIS AG (CH) | 2020-05-20 | — | — | EP | claimed |
| EP-3468972-A1 | COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 | NOVARTIS AG (CH) | 2019-04-17 | — | — | EP | claimed |
| EP-0717732-B1 | POLYAMIDIC ACID DERIVATIVES WITH ANTIGASTRIN ACTIVITY, A METHOD FOR THEIR PREPARATION, AND THEIR PHARMACEUTICAL USE | ROTTA RESEARCH LAB (IT) | 1998-07-29 | — | — | EP | claimed |
| WO-1997045415-A1 | POLYAMIDE DERIVATIVES OR ORNITHINE, LYSINE AND ANALOGOUS SUBSTANCES WITH CCK-B AND GASTRIN-ANTAGONISTIC ACTIVITY | ROTTA RESEARCH LABORATORIUM S.P.A. (IT) | 1997-12-04 | — | — | WO | claimed |
| WO-1997044341-A1 | CYCLIC POLYAMIDES OF GLUTAMIC ACID AND ASPARTIC ACID WITH ANTI-GASTRIN ACTIVITY, A METHOD FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE | ROTTA RESEARCH LABORATORIUM S.P.A. (IT) | 1997-11-27 | — | — | WO | claimed |
| EP-0345627-B1 | 9-R-azacyclic erythromycin antibiotics | ABBOTT LAB (US) | 1997-04-16 | — | — | EP | claimed |
| EP-0717732-A1 | POLYAMIDIC ACID DERIVATIVES WITH ANTIGASTRIN ACTIVITY, A METHOD FOR THEIR PREPARATION, AND THEIR PHARMACEUTICAL USE | ROTTA RESEARCH LABORATORIUM S.P.A. (IT) | 1996-06-26 | — | — | EP | claimed |
| US-5500430-A | Amidic derivatives of glutamic, aspartic and 2-amino adipic acids, a process for preparing same, and anti-gastrin composition containing the derivatives | ROTTA RESEARCH LABORATORIUM S.P.A. (IT) | 1996-03-19 | — | — | US | claimed |
| WO-1995007261-A1 | POLYAMIDIC ACID DERIVATIVES WITH ANTIGASTRIN ACTIVITY, A METHOD FOR THEIR PREPARATION, AND THEIR PHARMACEUTICAL USE | ROTTA RESEARCH LABORATORIUM S.P.A. (IT) | 1995-03-16 | — | — | WO | claimed |
| US-5075289-A | Improved activity and therapeutic ratios | ABBOTT LABORATORIES (US) | 1991-12-24 | — | — | US | claimed |
| EP-0345627-A2 | 9-R-azacyclic erythromycin antibiotics | ABBOTT LABORATORIES (US) | 1989-12-13 | — | — | EP | claimed |
| US-4104380-A | Dibenzyl glycolic acid derivatives | WARNER-LAMBERT COMPANY (US) | 1978-08-01 | — | — | US | claimed |